China Biotech Services Holdings Limited (HKG:8037)
Hong Kong
· Delayed Price · Currency is HKD 0.670
+0.010 (1.52%)
Apr 29, 2026, 3:54 PM HKT
HKG:8037 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | -198.15 | -95.45 | 258.09 | 19.39 | Upgrade
|
| Depreciation & Amortization | - | 21.42 | 55.58 | 66.4 | 68.11 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.11 | -0.3 | -2.78 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 84.57 | 21.19 | 1.72 | 0.19 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | -2.71 | -0.49 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | 7.68 | 4.18 | - | Upgrade
|
| Stock-Based Compensation | - | 0.3 | 1.89 | 2.02 | 5.25 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.68 | -1.14 | 3.9 | 0.52 | Upgrade
|
| Other Operating Activities | - | -9.9 | -295.23 | 587.43 | 173.34 | Upgrade
|
| Change in Accounts Receivable | - | -33.74 | 724.98 | -664.23 | -64.92 | Upgrade
|
| Change in Inventory | - | 0.21 | -2.22 | -13.99 | -2.41 | Upgrade
|
| Change in Accounts Payable | - | -17.4 | -232.89 | 237.1 | -158.27 | Upgrade
|
| Change in Other Net Operating Assets | - | - | 1.44 | 7.81 | 0.07 | Upgrade
|
| Operating Cash Flow | - | -151.89 | 191.72 | 482.75 | 40.51 | Upgrade
|
| Operating Cash Flow Growth | - | - | -60.28% | 1091.82% | -90.40% | Upgrade
|
| Capital Expenditures | - | -51.65 | -59.41 | -108.17 | -12.22 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.04 | 0.37 | 0.03 | - | Upgrade
|
| Divestitures | - | - | -0.04 | 5.37 | - | Upgrade
|
| Investment in Securities | - | 3.38 | 7.14 | -11.8 | 4.08 | Upgrade
|
| Other Investing Activities | - | 0.46 | -2.49 | -141.75 | 0.01 | Upgrade
|
| Investing Cash Flow | - | -47.77 | -54.43 | -256.31 | -8.12 | Upgrade
|
| Short-Term Debt Issued | - | 103.58 | 31.05 | 4.08 | 22.3 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 38.98 | - | Upgrade
|
| Total Debt Issued | - | 103.58 | 31.05 | 43.05 | 22.3 | Upgrade
|
| Short-Term Debt Repaid | - | -26.89 | - | -8.15 | -12.05 | Upgrade
|
| Long-Term Debt Repaid | - | -9.03 | -11.2 | -10.53 | -53.74 | Upgrade
|
| Total Debt Repaid | - | -35.92 | -11.2 | -18.68 | -65.8 | Upgrade
|
| Net Debt Issued (Repaid) | - | 67.66 | 19.86 | 24.37 | -43.5 | Upgrade
|
| Issuance of Common Stock | - | 4.74 | - | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | -3.64 | -2.99 | -4.31 | Upgrade
|
| Common Dividends Paid | - | - | -9.63 | - | - | Upgrade
|
| Other Financing Activities | - | 75.4 | -162.39 | -303.34 | -218.8 | Upgrade
|
| Financing Cash Flow | - | 147.81 | -155.8 | -281.96 | -266.61 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -1.32 | -2.18 | -2.26 | 0.25 | Upgrade
|
| Net Cash Flow | - | -53.17 | -20.68 | -57.78 | -233.99 | Upgrade
|
| Free Cash Flow | - | -203.54 | 132.31 | 374.58 | 28.29 | Upgrade
|
| Free Cash Flow Growth | - | - | -64.68% | 1224.12% | -90.42% | Upgrade
|
| Free Cash Flow Margin | - | -288.67% | 62.41% | 20.23% | 4.54% | Upgrade
|
| Free Cash Flow Per Share | - | -0.21 | 0.14 | 0.39 | 0.03 | Upgrade
|
| Cash Interest Paid | - | 5.87 | 6.39 | 3.83 | 3.29 | Upgrade
|
| Cash Income Tax Paid | - | -1.4 | 243.46 | 1.84 | -0.06 | Upgrade
|
| Levered Free Cash Flow | - | -3.65 | 57.36 | 186.61 | 25.28 | Upgrade
|
| Unlevered Free Cash Flow | - | 6.93 | 60.68 | 188.8 | 29.37 | Upgrade
|
| Change in Working Capital | - | -50.93 | 491.3 | -433.31 | -225.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.